MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-09-0024148
Jayro Pharmaceuticals Private Limited
Jayro Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹74.93 Lakh
▲ 11% YoY
Net profit · FY 2025
₹2.71 Lakh
Net margin 3.6%
EBITDA · FY 2025
₹5.2 Lakh
EBITDA margin 6.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Jayro Pharmaceuticals Private Limited
Data last updated:
Jayro Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC156933.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veithury Mallikarjun and Shiva Lingappa Nethi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.2 – 10/1 Nethaji Nagar Champapet, Hyderabad, Telangana, India – 500079.
As per the financials filed for FY 2025, the company reported a revenue of ₹74.93 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.71 Lakh (net margin 3.6%) and EBITDA of ₹5.2 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
Jayro Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0024148).
Company details
CIN U24290TG2021PTC156933
Registration Number 156933
Incorporation Date 12 November 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0024148
Recognitions & Rankings of Jayro Pharmaceuticals
Contact details
Jayro Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No.2 – 10/1 Nethaji Nagar Champapet, Hyderabad, Telangana, India – 500079
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jayro Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Jayro Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jayro Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Jayro Pharmaceuticals Private Limited, buy the company report.
Financials of Jayro Pharmaceuticals Private Limited
FY 2025 filings availableJayro Pharmaceuticals Private Limited reported revenue of ₹74.93 Lakh (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹74.93 Lakh ▲ 11%
Net profit · FY 2025
₹2.71 Lakh margin 3.6%
EBITDA · FY 2025
₹5.2 Lakh margin 6.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 62% over three years, including 11% growth in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.2 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.71 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.9% | |||
| Net Profit Margin | 3.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Jayro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jayro Pharmaceuticals Private Limited
Jayro Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veithury Mallikarjun | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
| Shiva Lingappa Nethi | Director | 31 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Jayro Pharmaceuticals Private Limited is audited by A.G.S.Reddy & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.G.S.Reddy & Co | FY 2023 | 233770 |
Shareholding
The shareholding of Jayro Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jayro Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jayro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jayro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jayro Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 21, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Jayro Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jayro Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Shiva Lingappa Nethi was appointed as Director on 31 Jul 2025.
AGM
Jayro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Shiva Lingappa Nethi was appointed as Director.
Ceased
Vasundara Tangirala ceased to be Director.
Filing
Jayro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Veithury Mallikarjun was appointed as Director.
Incorporation
12 Nov 2021
Jayro Pharmaceuticals Private Limited was registered on 12 Nov 2021 with Roc Hyderabad & aged 4 years 11 months as per MCA records.
Frequently asked questions
Jayro Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 November 2021 (5+ years old) and is registered under CIN U24290TG2021PTC156933.
Jayro Pharmaceuticals has 2 current directors:
- Veithury Mallikarjun - Director
- Shiva Lingappa Nethi - Director
The latest financial statements of Jayro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Jayro Pharmaceuticals is U24290TG2021PTC156933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jayro Pharmaceuticals was incorporated on 12 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shiva Lingappa Nethi was appointed as Director on 31 Jul 2025. Vasundara Tangirala ceased to be Director on 31 Jul 2025. Veithury Mallikarjun was appointed as Director on 12 Nov 2021.
Yes, Jayro Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0024148).
The registered office of Jayro Pharmaceuticals is at H No.2 – 101 Nethaji Nagar Champapet, Hyderabad, Telangana, India – 500079.
Jayro Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Jayro Pharmaceuticals can be reached at its registered office: H No.2 – 101 Nethaji Nagar Champapet, Hyderabad, Telangana, India – 500079.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages